Left Anterior Descending Coronary Artery Stenosis Clinical Trial
— OPSENSOfficial title:
The Drift-Reduction for Improved Fractional Flow Reserve (FFR) Using Fiberoptic Technology (DRIFT) Study
NCT number | NCT03848650 |
Other study ID # | AAAR7661 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 19, 2018 |
Est. completion date | January 2021 |
The primary objective of this study is to assess the accuracy, efficacy, and durability of the OpSens Medical OptoWire Deux pressure wire in the assessment of angiographically intermediate proximal left anterior descending coronary artery (LAD) stenoses in clinical practice.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | January 2021 |
Est. primary completion date | June 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male or female subjects, >18 years of age. - Patients with stable angina, unstable angina or non-ST segment elevation myocardial infarction (if the LAD lesion is the non-culprit lesion) and in whom an intermediate proximal LAD de novo stenosis (30-80%) with TIMI flow 3 has been identified on angiography. Note: Patients with multi-vessel disease can be enrolled. - Patients have had fractional flow reserve (FFR) and optical coherence tomography (OCT) of the LAD with the OpSens FFR system as part of their routine evaluation as standard of care procedure. - Provides written, informed consent and HIPAA consent to use the data in a clinical study. Exclusion Criteria: (General exclusion criteria) - Patients presented with NSTEMI with the LAD involved as the culprit lesion - Any ST-elevation myocardial infarction within the past 30 days. - Hemodynamic instability requiring vasopressor or mechanical circulatory support. - Prior heart transplant. - Known left ventricular ejection fraction =40%. - LAD supplying akinetic or severely hypokinetic territories if already known based on prior imaging. - Patient is enrolled in another clinical study that may impact the results of this study. - FFR not acquired per instructions for the OpSens Wire. - LAD Lesion not assessed with OCT. (Angiographic exclusion criteria) - Thrombolysis in Myocardial Infarction (TIMI) grade 2 or lower at baseline angiography. - Target lesion involves left main (stenosis >50%). - Previous percutaneous coronary intervention (PCI) with stent in LAD or left main trunk. - Presence of chronic total occlusion in any vessel. - Presence of a side branch=2.75 mm with =70% stenosis in the LAD. - Bifurcation lesion that resulted in the stent implantation of a side branch. |
Country | Name | City | State |
---|---|---|---|
United States | New York Presbyterian Hospital/Columbia University Medical Center | New York | New York |
United States | St. Francis Hospital | Roslyn | New York |
Lead Sponsor | Collaborator |
---|---|
Columbia University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of significant drift | This is to measure efficacy as defined as FFR <0.97 or >1.03 with the pre-PCI FFR recording using the OpSens OptoWire Deux pressure wire system | During procedure, approximately less than an hour |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05143671 -
Prospective Evaluation for Hybrid Cardiac Procedures
|
||
Recruiting |
NCT05726604 -
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
|
N/A |